bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
9.39
-1.11 (-10.57%)
At close: Sep 10, 2026, 4:00 PM EDT
9.49
+0.10 (1.06%)
After-hours: Sep 10, 2026, 6:52 PM EDT

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $1.51M in the quarter ending June 30, 2026, with 18.99% growth. This brings the company's revenue in the last twelve months to $5.90M, down -23.17% year-over-year. In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%.

Revenue (ttm)
$5.90M
Revenue Growth
-23.17%
P/S Ratio
0.86
Revenue / Employee
$103,526
Employees
57
Market Cap
5.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.16M-3.20M-34.18%
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MDxHealth114.02M
Biodesix102.94M
Burning Rock Biotech74.58M
Exagen71.12M
XWELL28.28M
Precipio27.20M
Insight Molecular Diagnostics1.67M
Quantum Cyber537.08K
Revenue Rankings